Discussion about this post

User's avatar
Kevin Kirkpatrick MSc.'s avatar

Thanks for the comment :) yes I also recommend clients take either hydroxy b12 or adenosyl b12 but I’ve also seen a lot of clients do well with methylb12 as well. Alternatively, I’ve seen a lot of people not react very well to taking too much methylb12 and I always encourage clients to get a lot of collagen in their diet or to supplement it so they have enough glycine to make sarcosine to serve as a buffer for overmethylation.

LongeviMed's avatar

Really enjoyed this framing, creatine is one of the rare supplements where the “gym bro” reputation has arguably outpaced the clinically interesting biology. The brain story makes sense mechanistically: the phosphocreatine system is a rapid ATP buffer, and neurons/glia lean on it when energetic demand spikes (sleep deprivation, stress, inflammation). So it’s plausible that creatine could nudge cognition, fatigue, and even mood in select groups, especially where baseline creatine availability is lower (e.g., low meat intake) or where mitochondrial/energetic strain is high. The early human data in depression/cognition is intriguing, but still heterogeneous and often small, so I love that you’re translating the promise without overselling certainty. Clinically, the “how” matters too: creatine monohydrate, third-party tested, usually 3–5 g/day; expect serum creatinine to rise a bit (often a lab artifact of higher creatine turnover rather than kidney injury), but I still caution patients with CKD or complex comorbidities to discuss with their clinician. Curious if in Part 2 you’ll cover which phenotypes seem to benefit most (sleep-deprived, perimenopause, SSRI adjunct, etc.) and what endpoints you’d track beyond “feel better”.

5 more comments...

No posts

Ready for more?